Literature DB >> 32587089

Ubiquitination of interleukin-1α is associated with increased pro-inflammatory polarization of murine macrophages deficient in the E3 ligase ITCH.

Xi Lin1, Hengwei Zhang1, Brendan F Boyce1,2, Lianping Xing3,2.   

Abstract

Macrophages play critical roles in homeostasis and inflammation. Macrophage polarization to either a pro-inflammatory or anti-inflammatory status is controlled by activating inflammatory signaling pathways. Ubiquitination is a posttranslational modification that regulates these inflammatory signaling pathways. However, the influence of protein ubiquitination on macrophage polarization has not been well studied. We hypothesized that the ubiquitination status of key proteins in inflammatory pathways contributes to macrophage polarization, which is regulated by itchy E3 ubiquitin ligase (ITCH), a negative regulator of inflammation. Using ubiquitin proteomics, we found that ubiquitination profiles are different among polarized murine macrophage subsets. Interestingly, interleukin-1α (IL-1α), an important pro-inflammatory mediator, was specifically ubiquitinated in lipopolysaccharide-induced pro-inflammatory macrophages, which was enhanced in ITCH-deficient macrophages. The ITCH-deficient macrophages had increased levels of the mature form of IL-1α and exhibited pro-inflammatory polarization, and reduced deubiquitination of IL-1α protein. Finally, IL-1α neutralization attenuated pro-inflammatory polarization of the ITCH-deficient macrophages. In conclusion, ubiquitination of IL-1α is associated with increased pro-inflammatory polarization of macrophages deficient in the E3 ligase ITCH.
© 2020 Lin et al.

Entities:  

Keywords:  IL-1α; Interleukin-1α; Itch; deubiquitination; deubiquitylation (deubiquitination); inflammation; innate immunity; interleukin 1 (IL-1); itchy E3 ubiquitin protein ligase (ITCH); macrophage; macrophage polarization; posttranslational modification; proteomics; ubiquitination; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2020        PMID: 32587089      PMCID: PMC7450106          DOI: 10.1074/jbc.RA120.014298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Identification of a Loss-of-Function Mutation in the Context of Glutaminase Deficiency and Neonatal Epileptic Encephalopathy.

Authors:  Lynne Rumping; Benjamin Büttner; Oliver Maier; Holger Rehmann; Maarten Lequin; Jan-Ulrich Schlump; Bernhard Schmitt; Birgit Schiebergen-Bronkhorst; Hubertus C M T Prinsen; Michele Losa; Ralph Fingerhut; Johannes R Lemke; Fried J T Zwartkruis; Roderick H J Houwen; Judith J M Jans; Nanda M Verhoeven-Duif; Peter M van Hasselt; Rami Jamra
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

2.  Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.

Authors:  Inna S Afonina; Graham A Tynan; Susan E Logue; Sean P Cullen; Michael Bots; Alexander U Lüthi; Emer P Reeves; Noel G McElvaney; Jan P Medema; Ed C Lavelle; Seamus J Martin
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

3.  The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes.

Authors:  Austin R Graves; Patricia K Curran; Carolyn L Smith; Joseph A Mindell
Journal:  Nature       Date:  2008-04-30       Impact factor: 49.962

4.  The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein.

Authors:  K Shimizu; M Tani; H Watanabe; Y Nagamachi; Y Niinaka; T Shiroishi; S Ohwada; A Raz; J Yokota
Journal:  FEBS Lett       Date:  1999-08-06       Impact factor: 4.124

5.  Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.

Authors:  Michael Murphy; Yanbao Xiong; Goutham Pattabiraman; Fu Qiu; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2015-06-16       Impact factor: 5.157

6.  Attenuated Joint Tissue Damage Associated With Improved Synovial Lymphatic Function Following Treatment With Bortezomib in a Mouse Model of Experimental Posttraumatic Osteoarthritis.

Authors:  Wensheng Wang; Xi Lin; Hao Xu; Wen Sun; Echoe M Bouta; Michael J Zuscik; Di Chen; Edward M Schwarz; Lianping Xing
Journal:  Arthritis Rheumatol       Date:  2019-01-05       Impact factor: 10.995

7.  Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch.

Authors:  Min Gao; Tord Labuda; Ying Xia; Ewen Gallagher; Deyu Fang; Yun-Cai Liu; Michael Karin
Journal:  Science       Date:  2004-09-09       Impact factor: 47.728

8.  Arabidopsis FAB1/PIKfyve proteins are essential for development of viable pollen.

Authors:  Paul Whitley; Steven Hinz; James Doughty
Journal:  Plant Physiol       Date:  2009-10-21       Impact factor: 8.340

9.  Ubiquitin E3 ligase Itch negatively regulates osteoclast formation by promoting deubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.

Authors:  Hengwei Zhang; Chengwu Wu; Lydia E Matesic; Xing Li; Zhiyu Wang; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

10.  Dendritic cell IL-1α and IL-1β are polyubiquitinated and degraded by the proteasome.

Authors:  Joseph S Ainscough; G Frank Gerberick; Maryam Zahedi-Nejad; Gloria Lopez-Castejon; David Brough; Ian Kimber; Rebecca J Dearman
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

View more
  2 in total

1.  UCHL1 Promoted Polarization of M1 Macrophages by Regulating the PI3K/AKT Signaling Pathway.

Authors:  Yulan Huang; Shitong He; Yitian Chen; Junli Sheng; Yuling Fu; Xialin Du; Yalong Yang; Honglin Liu; Zhenyu Han; Yingqi Huang; Qian Wen; Chaoying Zhou; Xinying Zhou; Shengfeng Hu; Li Ma
Journal:  J Inflamm Res       Date:  2022-02-04

2.  Transcriptome Analysis of Peripheral Blood Mononuclear Cells Response in Patients with Severe COVID-19 Reveals Crucial Genes Regulating Protein Ubiquitination.

Authors:  Jinfeng Huang; Ruobing Li; Jie Cheng; Peilin Zhen
Journal:  Med Sci Monit       Date:  2022-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.